Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒	QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2024

☐	TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT

For the transition period from ____________ to ______________

Commission file number: 000-55512

XENOUS HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

Nevada

87-0363526

(State or other jurisdiction of

incorporation or organization)

(IRS Employer

Identification No.)

Room 1120, 11th Floor, Peninsula Centre,

67 Mody Road

Tsim Sha Tsui, East Kowloon

Hong Kong

(Address of principal executive offices)

+852 6464-2017

(Registrant’s telephone number)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class:

Trading Symbol(s)

Name of each exchange on

which registered:

Common Stock

XITO

OTC Pink Sheets

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☐ No ☒

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated Filer	☐	Smaller reporting company	☒
(Do not check if a smaller reporting company)		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

The number of shares of the issuer’s common stock outstanding as of October 30, 2024 was 760,250,000 shares, par value $0.001 per share.

XENOUS HOLDINGS, INC.

FORM 10-Q

Quarterly Period Ended September 30, 2024

INDEX

		Page

PART I. FINANCIAL INFORMATION

Item 1.	Financial Statements	3
	Balance Sheets as of September 30, 2024 and March 31, 2024 (unaudited)	3
	Statements of Operations for the Six Months and Three Months ended September 30, 2024 and 2023 (unaudited)	4
	Statements of Changes in Stockholders' Deficit for the Six Months and Three Months ended September 30, 2024 and 2023 (unaudited)	5
	Statements of Cash Flows for the Six Months and Three Months ended September 30, 2024 and 2023 (unaudited)	6
	Notes to the Unaudited Condensed Financial Statements	7
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	10
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	12
Item 4.	Controls and Procedures	12

PART II. OTHER INFORMATION

Item 1.	Legal Proceedings	13
Item 1A.	Risk Factors	13
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	13
Item 3.	Defaults Upon Senior Securities	13
Item 4.	Mine Safety Disclosures	13
Item 5.	Other Information	13
Item 6.	Exhibits	14

SIGNATURES		15

Table of Contents

ITEM 1. FINANCIAL STATEMENTS

XENOUS HOLDINGS, INC.

Balance Sheets

	September 30, 2024			March 31, 2024
	(Unaudited)			(Audited)
ASSET

TOTAL ASSET	$	-		$	-

LIABILITIES AND STOCKHOLDERS' DEFICIT
Current Liabilities
Accounts payable and accrued liabilities	$	19,763		$	23,085
Due to a related party		850,558			816,081
Total Current Liabilities		870,321			839,166

TOTAL LIABILITIES		870,321			839,166

STOCKHOLDERS' DEFICIT
Preferred stock, par value $0.001 per share, 10,000,000 shares authorized, no shares issued and outstanding		-			-
Common stock, par value $0.001 per share, 10,000,000,000 shares authorized, 760,250,000 shares issued and outstanding		760,250			760,250
Capital deficiency		(449,450	)		(449,450	)
Accumulated deficit		(1,181,121	)		(1,149,966	)
Total Stockholders' Deficit		(870,321	)		(839,166	)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$	-		$	-

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

XENOUS HOLDINGS, INC.

Statements of Operations

(Unaudited)

	For the Three Months Ended						For the Six Months Ended
	September 30,			September 30,			September 30,			September 30,
	2024			2023			2024			2023

OPERATING EXPENSES
General and administrative	$	604		$	351		$	920		$	980
Professional fees		14,580			14,679			30,235			29,559
		15,184			15,030			31,155			30,539

NET LOSS	$	(15,184	)	$	(15,030	)	$	(31,155	)	$	(30,539	)

Basic and Diluted Loss per Common Share	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)

Basic and Diluted Weighted Average Number of Common Shares		760,250,000			760,250,000			760,250,000			760,250,000

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

XENOUS HOLDINGS, INC.

Statements of Changes in Stockholders’ Deficit

For the six months ended September 30, 2024 and 2023

(Unaudited)

Six Months Ended September 30, 2024

	Common Stock										Total
	Number of Shares		Amount		Capital Deficiency			Accumulated Deficit			Stockholders' Deficit

Balance - March 31, 2024		760,250,000	$	760,250	$	(449,450	)	$	(1,149,966	)	$	(839,166	)

Net loss		-		-		-			(15,971	)		(15,971	)
Balance - June 30, 2024		760,250,000	$	760,250	$	(449,450	)	$	(1,165,937	)	$	(855,137	)

Net loss		-		-		-			(15,184	)		(15,184	)
Balance - September 30, 2024		760,250,000	$	760,250	$	(449,450	)	$	(1,181,121	)	$	(870,321	)

Six Months Ended September 30, 2023

	Common Stock										Total
	Number of Shares		Amount		Capital Deficiency			Accumulated Deficit			Stockholders' Deficit

Balance - March 31, 2023		760,250,000	$	760,250	$	(449,450	)	$	(1,086,220	)	$	(775,420	)

Net loss		-		-		-			(15,509	)		(15,509	)
Balance - June 30, 2023		760,250,000	$	760,250	$	(449,450	)	$	(1,101,729	)	$	(790,929	)

Net loss		-		-		-			(15,030	)		(15,030	)
Balance - September 30, 2023		760,250,000	$	760,250	$	(449,450	)	$	(1,116,759	)	$	(805,959	)

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

XENOUS HOLDINGS, INC.

Statements of Cash Flows

(Unaudited)

	For the Six Months Ended
	September 30,			September 30,
	2024			2023

CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$	(31,155	)	$	(30,539	)
Changes in operating assets and liabilities:
Accounts payable and accrued liabilities		(3,322	)		6,708
Net cash used in operating activities		(34,477	)		(23,831	)

CASH FLOWS FROM FINANCING ACTIVITY
Proceeds from related party advances		34,477			23,831
Net cash provided by financing activity		34,477			23,831

Net changes in cash and cash equivalents		-			-
Cash and cash equivalents - beginning of period		-			-
Cash and cash equivalents - end of period	$	-		$	-

Supplemental Cash Flow Disclosures
Cash paid for interest	$	-		$	-
Cash paid for income taxes	$	-		$	-

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

XENOUS HOLDINGS, INC.

Notes to the Unaudited Condensed Financial Statements

September 30, 2024

NOTE 1 - NATURE OF BUSINESS AND CONTINUANCE OF OPERATIONS

Xenous Holdings, Inc. (the “Company”) was incorporated on May 20, 1980 as Dayne Weiss and Associates, Inc. under the laws of the State of Utah.

On December 19, 2014, the Company completed a change of domicile merger with Concept Holding Corp., a Nevada corporation, which became the surviving entity.

On July 21, 2017, the Board of Directors of the Company elected to file Articles of Merger with the Nevada SOS whereby it would enter into a statutory merger with its wholly-owned subsidiary, M101 Corp., a Nevada corporation, pursuant to Nevada Revised Statutes 92A.200, et seq. The effect of such merger is the Company is the surviving entity and changed its name to “M101 Corp.” The merger took effect on August 14, 2017.

On November 2, 2019, a majority of shareholders approved a resolution to change the name of the Company to Xenous Holdings, Inc. On November 19, 2019, the Company received notice that the Secretary of State of Nevada accepted the Company’s Certificate of Amendment to its Articles of Incorporation to change the name of the Company to Xenous Holdings, Inc. The Company currently has no business operations.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the six months ended September 30, 2024 are not necessarily indicative of the results that may be expected for the year ending March 31, 2025. The notes to the unaudited financial statements are condensed, as disclosures that would substantially duplicate the disclosures contained in the audited financial statements for fiscal year 2024 have been omitted. This report should be read in conjunction with the audited financial statements and the footnotes thereto for the fiscal year ended March 31, 2024 included in the Company’s Form 10-K as filed with the Securities and Exchange Commission on June 27, 2024.

Use of Estimates

The Company prepares its financial statements in conformity with “GAAP,” which require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Fair Value of Financial Instruments

ASC 820 “Fair Value Measurements and Disclosures” establishes a three-tier fair value hierarchy, which prioritizes the inputs in measuring fair value. The hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market.

These tiers include:

Level 1: defined as observable inputs such as quoted prices in active markets;

Level 2: defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and

Level 3: defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.

Table of Contents

The Company’s financial instruments consist primarily of accounts payable and debts. The carrying amounts of such financial instruments approximate their respective estimated fair value due to the short-term maturities and approximate market interest rates of these instruments.

Basic and Diluted Earnings Per Share

The Company has adopted ASC Topic 260, ”Earnings per Share,”(“EPS”) which requires presentation of basic EPS on the face of the income statement for all entities with complex capital structures and requires a reconciliation of the numerator and denominator of the basic EPS computation. In the accompanying financial statements, basic earnings (loss) per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period.

As of September 30, 2024 and 2023, the Company did not have any potentially dilutive securities.

Related Parties

We follow ASC 850,“Related Party Disclosures” for the identification of related parties and disclosure of related party transactions. (see Note 4).

Recently Issued Accounting Pronouncements

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740) - Improvements to Income Tax Disclosures ("ASU 2023-09"), which is intended to enhance the transparency and decision usefulness of income tax disclosures. The amendments in ASU 2023-09 provide for enhanced income tax information primarily through changes to the rate reconciliation and income taxes paid information. ASU 2023-09 is effective for the Company prospectively to all annual periods beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact this update will have on our unaudited condensed consolidated financial statements and disclosures.

In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures ("ASU 2023-07"), which require public companies disclose significant segment expenses and other segment items on an annual and interim basis and to provide in interim periods all disclosures about a reportable segment's profit or loss and assets that are currently required annually. The guidance is effective for public entities for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The guidance is applied retrospectively to all periods presented in the financial statements, unless it is impracticable. We are currently evaluating the impact this update will have on our unaudited condensed consolidated financial statements and disclosures.

NOTE 3 - GOING CONCERN

The Company has not yet generated any revenue since its inception and has an operating loss and net loss of $31,155 for the six months ended September 30, 2024. As of September 30, 2024, the Company has accumulated deficit of $1,181,121, negative operating cash flow of $34,477 and negative working capital of $870,321. The Company’s continuation as a going concern is dependent on its ability to execute its operation plan to generate sufficient cash flows from operations to meet its obligations and/or obtaining additional financing from its major shareholder or other sources, as may be required. There can be no assurance that the necessary debt or equity financing will be available or will be available on terms acceptable to the Company.

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern; however, the above conditions raise substantial doubt about the Company’s ability to do so. The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should the Company be unable to continue as a going concern.

While we believe in the viability of our strategy to generate sufficient revenues in the future and in our ability to raise additional funds, there can be no assurances to that effect.

Table of Contents

NOTE 4 - RELATED PARTY TRANSACTIONS

Due to Related Party

During the six months ended September 30, 2024 and 2023, Smartex Investment Ltd., the majority shareholder of the Company which is holding 82% of the Company’s common shares, advanced $34,477 and $23,831, respectively, to the Company for operating expenses. As of September 30, 2024 and March 31, 2024, total amount due to Smartex Investment Ltd. was $850,558 and $816,081 respectively. The loan is non-interest bearing and due on demand.

NOTE 5 – SHARE CAPITAL

Preferred Stock

The Company is authorized to issue 10,000,000 shares of preferred stock with a par value of $0.001 per share. As of September 30, 2024 and March 31, 2024, no preferred shares have been issued.

Common Stock

The Company is authorized to issue 10,000,000,000 shares of common stock with a par value of $0.001 per share.

There were no stock issuances during the six months ended September 30, 2024 and 2023. As of September 30, 2024 and March 31, 2024, the Company had 760,250,000 shares of common stock issued and outstanding.

NOTE 6 – SUBSEQUENT EVENTS

In accordance with ASC 855-10, the Company has analyzed its operations subsequent to September 30, 2024 to the date these financial statements were issued and has determined that it does not have other material subsequent events to disclose in these financial statements except as stated below:

In November 2022, the Company announced that it was conducting a full financial and legal due diligence of a Malaysia-based company involving the plantations, inoculations, cultivations, manufacturing, marketing, trading and conducting research and development of agricultural commodities in relation to Aquilaria trees and its related products. The preliminary due diligence for its target acquisition company has been successfully completed. This critical first phase has yielded a positive outcome, confirming our confidence in the potential value of the target company. The Company is now progressing with further due diligence, specifically focusing on the intangible assets and the valuation of these assets. This thorough assessment is essential to ensure a comprehensive evaluation of the acquisition target. The due diligence process is expected to be completed by the last quarter of calendar year 2024. Following the successful conclusion of this final phase, the acquisition will proceed formally, in line with our previous announcements. The Company remains committed to transparency and will continue to keep stakeholders informed of any significant developments. We appreciate the ongoing support from our investors, partners, and customers as we move forward with this strategic acquisition.

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS.

When used in this Quarterly Report, the words “may,” “will,” “expect,” “anticipate,” “continue,” “estimate,” “project,” “intend,” and similar expressions are intended to identify forward-looking statements regarding events, conditions, and financial trends that may affect our future plans of operations, business strategy, operating results, and financial position. Persons reviewing this Quarterly Report are cautioned that any forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties and actual results may differ materially from those included within the forward-looking statements as a result of various factors. Such factors are discussed further below and also include general economic factors and conditions that may directly or indirectly impact our financial condition or results of operations.

Plan of Operation

Our plan of operation for the next 12 months is to: (i) consider guidelines of industries in which we may have an interest; (ii) adopt a business plan regarding engaging in the business of any selected industry; and (iii) to commence such operations through funding and/or the acquisition of a “going concern” engaged in any industry selected.

During the next 12 months, our only foreseeable cash requirements will relate to maintaining our good standing or the payment of expenses associated with legal fees, accounting fees and reviewing or investigating any potential business venture, which may be advanced by management or principal stockholders as loans to us. Because we have not determined any business or industry in which our operations will be commenced, and we have not identified any prospective venture as of the date of this Annual Report, it is impossible to predict the amount of any such loan. Any such loan will be on terms no less favorable to us than would be available from a commercial lender in an arm’s length transaction. No advance or loan from any affiliate will be required to be repaid as a condition to any agreement with future acquisition partners.

Results of Operations

Three Months Ended September 30, 2024 and 2023

	Three Months			Three Months
	Ended			Ended
	September 30,			September 30,
	2024			2023			Changes

Operating Expenses	$	15,184		$	15,030		$	154
Net Loss	$	(15,184	)	$	(15,030	)	$	(154	)

We had no operations during the three months ended September 30, 2024 or 2023, nor do we have operations as of the date of this filing. We had a net loss of $15,184 and $15,030 for the three months ended September 30, 2024 and 2023, respectively. The increase in net loss was mainly attributable by the increase in professional fees.

Six Months Ended September 30, 2024 and 2023

	Six Months			Six Months
	Ended			Ended
	September 30,			September 30,
	2024			2023			Changes

Operating Expenses	$	31,155		$	30,539		$	616
Net Loss	$	(31,155	)	$	(30,539	)	$	(616	)

We had no operations during the six months ended September 30, 2024 or 2023, nor do we have operations as of the date of this filing. We had a net loss of $31,155 and $30,539 for the six months ended September 30, 2024 and 2023, respectively. The increase in net loss was mainly attributable by the increase in professional fees.

Table of Contents

Liquidity and Capital Resources

	As of			As of
	September 30,			March 31,
	2024			2024			Changes

Current Assets	$	-		$	-		$	-
Current Liabilities	$	870,321		$	839,166		$	31,155
Working Capital (Deficiency)	$	(870,321	)	$	(839,166	)	$	(31,155	)

As of September 30, 2024 and March 31, 2024, we had no current asset.

As of September 30, 2024 and March 31, 2024, our total liabilities were $870,321 and $839,166, respectively, which were current liabilities comprised of accounts payable, accrued liabilities, and related party advances.

Stockholders’ deficit was at $1,181,121 as of September 30, 2024, compared to deficit of $1,149,966 as of March 31, 2024.

We had no cash on hand as of September 30, 2024 or March 31, 2024 to meet ongoing expenses and debts that may accumulate. Accumulated deficit was at $1,181,121 as of September 30, 2024, compared to accumulated deficit of $1,149,966 as of March 31, 2024.

As of September 30, 2024, we had a working capital deficit of $870,321 compared with a working capital deficit of $839,166 as of March 31, 2024. The increase in working capital deficit was attributed to an increase in due to related party for advancement from the Company’s majority shareholder paying off vendors on behalf of the Company.

	Six Months			Six Months
	Ended			Ended
	September 30,			September 30,
	2024			2023			Changes

Net cash used in operating activities	$	(34,477	)	$	(23,831	)	$	(10,646	)
Net cash provided by financing activities	$	34,477		$	23,831		$	10,646
Net changes in cash and cash equivalents	$	-		$	-		$	-

Cash Flow from Operating Activities

We have not generated any positive cash flow from operating activities.

For the six months ended September 30, 2024, net cash flows used in operating activities was $34,477. The net cash used in operating activities for the six months ended September 30, 2024 was attributed by a net loss of 31,155, increased by an decrease in accounts payable and accrued liabilities of $3,322.

For the six months ended September 30, 2023, net cash flows used in operating activities was $23,831. The net cash used in operating activities for the six months ended September 30, 2023 was attributed by a net loss of 30,539, decreased by an increase in accounts payable and accrued liabilities of $6,708.

Cash Flow from Investing Activities

During the six months ended September 30, 2024 and 2023, we had no investing activities.

Cash Flow from Financing Activities

We have financed our operations primarily from advances and loans from Smartex Investment Ltd., majority shareholder of the Company.

For the six months ended September 30, 2024 and 2023, net cash from financing activities was $34,477 and $23,831, respectively.

Table of Contents

Going Concern

Our independent auditors have added an explanatory paragraph to their audit issued in connection with the financial statements for the year ended March 31, 2024, relative to our ability to continue as a going concern. The Company, which has not generated any revenues, has incurred net losses, has net current liabilities and a stockholders’ deficit. These conditions, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s continuation as a going concern is dependent on its ability to meet its obligations, to obtain additional financing as may be required and ultimately to attain profitability. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

The Company is dependent on advances from its principal shareholders or other affiliated parties for continued funding. There are no commitments or guarantees from any third party to provide such funding nor is there any guarantee that the Company will be able to access the funding it requires to continue its operations.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to an investor in our securities.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Pursuant to Item 305(e) of Regulation of S-K (§229.305(e)), the Company is not required to provide the information required by this Item as it is a “smaller reporting company,” as defined by Rule 229.10(f)(1).

ITEM 4. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

Disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) are designed to ensure that information required to be disclosed in reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in rules and forms adopted by the Securities and Exchange Commission, and that such information is accumulated and communicated to management, including the Chief Executive Officer and Secretary, to allow timely decisions regarding required disclosures.

Under the supervision and with the participation of our management, including our Chief Executive Officer and Secretary, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this Quarterly Report. Based upon that evaluation, our Chief Executive Officer and Secretary concluded that, as of the end of the period covered by this Quarterly Report, our disclosure controls and procedures were not effective.

Changes in Internal Control Over Financial Reporting

During the fiscal quarter covered by this Quarterly Report, there has been no change in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

PART II – OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

Management is not aware of any legal proceedings contemplated by any governmental authority or any other party involving us. As of the date of this Quarterly Report, no director, officer or affiliate is (i) a party adverse to us in any legal proceeding, or (ii) has an adverse interest to us in any legal proceedings. Management is not aware of any other legal proceedings pending or that have been threatened against us.

ITEM 1A. RISK FACTORS

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, the Company is not required to provide this information.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

There were no unregistered sales of our equity securities during the period covered by this quarterly report.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4.MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

None.

Table of Contents

ITEM 6. EXHIBITS

Exhibits:

31.1		Rule 13(a)-14(a)/15(d)-14(a) Certification of Chief Executive Officer
31.2		Rule 13(a)-14(a)/15(d)-14(a) Certification of Chief Financial Officer
32.1		Section 1350 Certification by Chief Executive Officer
32.2		Section 1350 Certification by Chief Financial Officer

Table of Contents

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	XENOUS HOLDINGS, INC.

DATED: November 14, 2024	By:	/s/ Jonathan Chan Ye Earn
		Jonathan Chan Ye Earn
		Chief Executive Officer (Principal Executive Officer)

	By:	/s/ Stephanie Mak
		Stephanie Mak
		Chief Financial Officer (Principal Financial Officer)

nullnullnullnull

Cover - shares	6 Months Ended
Cover - shares	Sep. 30, 2024	Oct. 30, 2024
Cover [Abstract]
Entity Registrant Name	XENOUS HOLDINGS, INC.
Entity Central Index Key	0001651932
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--03-31
Entity Small Business	true
Entity Shell Company	true
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Document Period End Date	Sep. 30, 2024
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2025
Entity Common Stock Shares Outstanding		760,250,000
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	000-55512
Entity Incorporation State Country Code	NV
Entity Tax Identification Number	87-0363526
Entity Address Address Line 1	Room 1120, 11th Floor, Peninsula Centre
Entity Address Address Line 2	67 Mody Road
Entity Address Address Line 3	Tsim Sha Tsui
Entity Address City Or Town	East Kowloon
City Area Code	852
Local Phone Number	6464-2017
Security 12b Title	Common Stock
Trading Symbol	XITO
Entity Interactive Data Current	No
Entity Address Country	HK

Balance Sheets - USD ($)	Sep. 30, 2024	Mar. 31, 2024
ASSET
TOTAL ASSET	$ 0	$ 0
Current Liabilities
Accounts payable and accrued liabilities	19,763	23,085
Due to a related party	850,558	816,081
Total Current Liabilities	870,321	839,166
TOTAL LIABILITIES	870,321	839,166
STOCKHOLDERS' DEFICIT
Preferred stock, par value $0.001 per share, 10,000,000 shares authorized, no shares issued and outstanding	0	0
Common stock, par value $0.001 per share, 10,000,000,000 shares authorized, 760,250,000 shares issued and outstanding	760,250	760,250
Capital deficiency	(449,450)	(449,450)
Accumulated deficit	(1,181,121)	(1,149,966)
Total Stockholders' Deficit	(870,321)	(839,166)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 0	$ 0

Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2024	Mar. 31, 2024
STOCKHOLDERS' DEFICIT
Preferred stock, shares par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, shares par value	$ 0.001	$ 0.001
Common stock, shares authorized	10,000,000,000	10,000,000,000
Common stock, shares issued	760,250,000	760,250,000
Common stock, shares outstanding	760,250,000	760,250,000

Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
Statements of Operations (Unaudited) - USD ($)	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
OPERATING EXPENSES
General and administrative	$ 604	$ 351	$ 920	$ 980
Professional fees	14,580	14,679	30,235	29,559
Operating Expenses	15,184	15,030	31,155	30,539
NET LOSS	$ (15,184)	$ (15,030)	$ (31,155)	$ (30,539)
Basic and Diluted Loss per Common Share	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)
Basic and Diluted Weighted Average Number of Common Shares	760,250,000	760,250,000	760,250,000	760,250,000

Statements of Changes in Stockholders Deficit (Unaudited) - USD ($)	Total	Common Stock	Capital Deficiency	Accumulated Deficit
Balance, shares at Mar. 31, 2023		760,250,000
Balance, amount at Mar. 31, 2023	$ (775,420)	$ 760,250	$ (449,450)	$ (1,086,220)
Net loss	(15,509)			(15,509)
Balance, shares at Jun. 30, 2023		760,250,000
Balance, amount at Jun. 30, 2023	(790,929)	$ 760,250	(449,450)	1,101,729
Balance, shares at Mar. 31, 2023		760,250,000
Balance, amount at Mar. 31, 2023	(775,420)	$ 760,250	(449,450)	(1,086,220)
Net loss	(30,539)
Balance, shares at Sep. 30, 2023		760,250,000
Balance, amount at Sep. 30, 2023	(805,959)	$ 760,250	(449,450)	(1,116,759)
Balance, shares at Jun. 30, 2023		760,250,000
Balance, amount at Jun. 30, 2023	(790,929)	$ 760,250	(449,450)	1,101,729
Net loss	(15,030)			(15,030)
Balance, shares at Sep. 30, 2023		760,250,000
Balance, amount at Sep. 30, 2023	(805,959)	$ 760,250	(449,450)	(1,116,759)
Balance, shares at Mar. 31, 2024		760,250,000
Balance, amount at Mar. 31, 2024	(839,166)	$ 760,250	(449,450)	(1,149,966)
Net loss	(15,971)	$ 0	0	(15,971)
Balance, shares at Jun. 30, 2024		760,250,000
Balance, amount at Jun. 30, 2024	(855,137)	$ 760,250	(449,450)	(1,165,937)
Balance, shares at Mar. 31, 2024		760,250,000
Balance, amount at Mar. 31, 2024	(839,166)	$ 760,250	(449,450)	(1,149,966)
Net loss	(31,155)
Balance, shares at Sep. 30, 2024		760,250,000
Balance, amount at Sep. 30, 2024	(870,321)	$ 760,250	(449,450)	(1,181,121)
Balance, shares at Jun. 30, 2024		760,250,000
Balance, amount at Jun. 30, 2024	(855,137)	$ 760,250	(449,450)	(1,165,937)
Net loss	(15,184)	$ 0	0	(15,184)
Balance, shares at Sep. 30, 2024		760,250,000
Balance, amount at Sep. 30, 2024	$ (870,321)	$ 760,250	$ (449,450)	$ (1,181,121)

Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
Statements of Cash Flows (Unaudited) - USD ($)	Sep. 30, 2024	Sep. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (31,155)	$ (30,539)
Changes in operating assets and liabilities:
Accounts payable and accrued liabilities	(3,322)	6,708
Net cash used in operating activities	(34,477)	(23,831)
CASH FLOWS FROM FINANCING ACTIVITY
Proceeds from related party advances	34,477	23,831
Net cash provided by financing activity	34,477	23,831
Net changes in cash and cash equivalents	0	0
Cash and cash equivalents - beginning of period	0	0
Cash and cash equivalents - end of period	0	0
Supplemental Cash Flow Disclosures
Cash paid for interest	0	0
Cash paid for income taxes	$ 0	$ 0

NATURE OF BUSINESS AND CONTINUANCE OF OPERATIONS

6 Months Ended

Sep. 30, 2024

NATURE OF BUSINESS AND CONTINUANCE OF OPERATIONS

NATURE OF BUSINESS AND CONTINUANCE OF OPERATIONS

NOTE 1 - NATURE OF BUSINESS AND CONTINUANCE OF OPERATIONS

Xenous Holdings, Inc. (the “Company”) was incorporated on May 20, 1980 as Dayne Weiss and Associates, Inc. under the laws of the State of Utah.

On December 19, 2014, the Company completed a change of domicile merger with Concept Holding Corp., a Nevada corporation, which became the surviving entity.

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

6 Months Ended

Sep. 30, 2024

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

Use of Estimates

Fair Value of Financial Instruments

These tiers include:

Level 1: defined as observable inputs such as quoted prices in active markets;

Level 2: defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and

Level 3: defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.

Basic and Diluted Earnings Per Share

As of September 30, 2024 and 2023, the Company did not have any potentially dilutive securities.

Related Parties

We follow ASC 850,“Related Party Disclosures” for the identification of related parties and disclosure of related party transactions. (see Note 4).

Recently Issued Accounting Pronouncements

GOING CONCERN

6 Months Ended

Sep. 30, 2024

GOING CONCERN

GOING CONCERN

NOTE 3 - GOING CONCERN

While we believe in the viability of our strategy to generate sufficient revenues in the future and in our ability to raise additional funds, there can be no assurances to that effect.

RELATED PARTY TRANSACTIONS

6 Months Ended

Sep. 30, 2024

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS

NOTE 4 - RELATED PARTY TRANSACTIONS

Due to Related Party

SHARE CAPITAL

6 Months Ended

Sep. 30, 2024

SHARE CAPITAL

SHARE CAPITAL

NOTE 5 – SHARE CAPITAL

Preferred Stock

The Company is authorized to issue 10,000,000 shares of preferred stock with a par value of $0.001 per share. As of September 30, 2024 and March 31, 2024, no preferred shares have been issued.

Common Stock

The Company is authorized to issue 10,000,000,000 shares of common stock with a par value of $0.001 per share.

SUBSEQUENT EVENTS

6 Months Ended

Sep. 30, 2024

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS

NOTE 6 – SUBSEQUENT EVENTS

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	Sep. 30, 2024
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation	The accompanying unaudited condensed financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the six months ended September 30, 2024 are not necessarily indicative of the results that may be expected for the year ending March 31, 2025. The notes to the unaudited financial statements are condensed, as disclosures that would substantially duplicate the disclosures contained in the audited financial statements for fiscal year 2024 have been omitted. This report should be read in conjunction with the audited financial statements and the footnotes thereto for the fiscal year ended March 31, 2024 included in the Company’s Form 10-K as filed with the Securities and Exchange Commission on June 27, 2024.
Use of Estimates	The Company prepares its financial statements in conformity with “GAAP,” which require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Fair Value of Financial Instruments	ASC 820 “Fair Value Measurements and Disclosures” establishes a three-tier fair value hierarchy, which prioritizes the inputs in measuring fair value. The hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. These tiers include: Level 1: defined as observable inputs such as quoted prices in active markets; Level 2: defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3: defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions. The Company’s financial instruments consist primarily of accounts payable and debts. The carrying amounts of such financial instruments approximate their respective estimated fair value due to the short-term maturities and approximate market interest rates of these instruments.
Basic and Diluted Earnings Per Share	The Company has adopted ASC Topic 260, ”Earnings per Share,”(“EPS”) which requires presentation of basic EPS on the face of the income statement for all entities with complex capital structures and requires a reconciliation of the numerator and denominator of the basic EPS computation. In the accompanying financial statements, basic earnings (loss) per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. As of September 30, 2024 and 2023, the Company did not have any potentially dilutive securities.
Related Parties	We follow ASC 850,“Related Party Disclosures” for the identification of related parties and disclosure of related party transactions. (see Note 4).
Recently Issued Accounting Pronouncements	The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations. In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740) - Improvements to Income Tax Disclosures ("ASU 2023-09"), which is intended to enhance the transparency and decision usefulness of income tax disclosures. The amendments in ASU 2023-09 provide for enhanced income tax information primarily through changes to the rate reconciliation and income taxes paid information. ASU 2023-09 is effective for the Company prospectively to all annual periods beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact this update will have on our unaudited condensed consolidated financial statements and disclosures. In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures ("ASU 2023-07"), which require public companies disclose significant segment expenses and other segment items on an annual and interim basis and to provide in interim periods all disclosures about a reportable segment's profit or loss and assets that are currently required annually. The guidance is effective for public entities for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The guidance is applied retrospectively to all periods presented in the financial statements, unless it is impracticable. We are currently evaluating the impact this update will have on our unaudited condensed consolidated financial statements and disclosures.

GOING CONCERN (Detail Narrative) - USD ($)	3 Months Ended				6 Months Ended
GOING CONCERN (Detail Narrative) - USD ($)	Sep. 30, 2024	Jun. 30, 2024	Sep. 30, 2023	Jun. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Mar. 31, 2024
GOING CONCERN
Net cash used in operating activities					$ (34,477)	$ (23,831)
Net loss	$ (15,184)	$ (15,971)	$ (15,030)	$ (15,509)	(31,155)	$ (30,539)
Accumulated deficit	$ (1,181,121)				(1,181,121)		$ (1,149,966)
Working capital					$ 870,321

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	6 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Mar. 31, 2024
Proceeds from related party advances	$ 34,477	$ 23,831
Due to a related party	850,558		$ 816,081
Smartex Investment Ltd [Member]
Proceeds from related party advances	$ 34,477	$ 23,831
Ownership percentage	82.00%
Due to a related party	$ 850,558		$ 816,081

SHARE CAPITAL (Details Narrative) - $ / shares	Sep. 30, 2024	Mar. 31, 2024
SHARE CAPITAL
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	10,000,000,000	10,000,000,000
Common stock, shares issued	760,250,000	760,250,000
Common stock, shares outstanding	760,250,000	760,250,000

Xenous (PK) (USOTC:XITO)
Historical Stock Chart
From Nov 2024 to Dec 2024

Xenous (PK) (USOTC:XITO)
Historical Stock Chart
From Dec 2023 to Dec 2024

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

XITO Xenous Holdings Inc (PK)

Latest XITO Messages

Loading Messages....

Xenous Holdings Inc (PK) News

Loading Messages....

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

XITO Xenous Holdings Inc (PK)

Latest XITO Messages

Loading Messages....

Xenous Holdings Inc (PK) News

Loading Messages....

Your Recent History

Company

Business

Popular

Get The App